Water Vapor Ablation for Prostate Cancer: Long-Term Registry

ClinicalTrials.gov ID

NCT07455058

Lead Sponsor

Francis Medical Inc.INDUSTRY

Overall Status

Recruiting

Study Type

Observational

Enrollment

2,500Estimated

Last Update Posted

Aug 18, 2026Actual

Start Date

Jun 5, 2026Actual

Primary Completion Date

Apr 30, 2041Estimated

Completion Date

Jul 31, 2041Estimated

Official Title

Vanquish® Water Vapor Ablation for PrOstate CanceR: Long-Term Registry

Brief Summary

The purpose of the registry is to evaluate real-world safety, efficacy, and patient reported outcomes among participants receiving Vanquish Water Vapor Ablation System therapy (Vanquish Therapy). This includes longitudinal assessment of patients who have received or will receive the therapy one or multiple times as part of routine clinical care and encompasses those who completed a company-sponsored Vanquish therapy study (as applicable).

• Prostate Cancer

• Vanquish Therapy

Ages Eligible for Study

Child (0-17)Adult (18-64)Older Adult (65+)

Sexes Eligible for Study

Male

Accepts Healthy Volunteers

No

Eligibility Criteria

Inclusion Criteria:

• Candidate for Vanquish therapy per physician discretion or participant has completed a company-sponsored Vanquish therapy study.
• Participant is willing and able to provide written informed consent.

Exclusion Criteria:

• Contraindications per the Vanquish IFU
• Previously participated in VAPOR 2 study and is not planning to receive further Vanquish therapy.

Observational Model

Case-Only

Time Perspective

Prospective

Lead Sponsor

Francis Medical Inc.INDUSTRY

mrobb@mnurology.com651-999-6800

• Water Vapor Ablation for Grade Group 3 Prostate Cancer

  NCT07652164

  Not yet recruitingInterventionalNot ApplicableUpdated Aug 11, 2026
• Water Vapor Ablation for Localized Intermediate Risk Prostate Cancer

  NCT05683691

  Active, not recruitingInterventionalNot ApplicableUpdated Jun 15, 2026
• Transurethral Periprostatectomy Treatment of Cancerous Prostate Tissue

  NCT07561502

  CompletedInterventionalNot ApplicableUpdated May 1, 2026
• Evaluation of the Water Vapor Thermal Therapy System for the Treatment of Benign Prostatic Hyperplasia

  NCT06725212

  RecruitingInterventionalNot ApplicableUpdated Dec 17, 2024
• Ablation of Prostate Tissue Utilizing Sterile Water Vapor in Patients With Intermediate Risk Localized Prostate Cancer

  NCT04087980

  CompletedInterventionalNot ApplicableUpdated Jul 26, 2022
• WATER IV Prostate Cancer

  NCT06651632

  Active, not recruitingInterventionalNot ApplicableUpdated May 4, 2026